These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23419663)

  • 1. Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.
    Wu D; Xu J; Yu G; Zhang B; Wang H; Wang C; Ru G; Sun A; Shen L; Wei Q
    Hepatogastroenterology; 2013; 60(121):99-106. PubMed ID: 23419663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.
    Zhan N; Dong WG; Tang YF; Wang ZS; Xiong CL
    Med Oncol; 2012 Jun; 29(2):933-40. PubMed ID: 21318736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
    Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
    Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
    Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
    Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
    Thompson SK; Sullivan TR; Davies R; Ruszkiewicz AR
    Ann Surg Oncol; 2011 Jul; 18(7):2010-7. PubMed ID: 21267790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression.
    Chen PC; Yu HJ; Chang YH; Pan CC
    J Clin Pathol; 2013 Feb; 66(2):113-9. PubMed ID: 23087329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma.
    Kawamura T; Kanno R; Fujii H; Suzuki T
    Pathobiology; 2005; 72(5):233-40. PubMed ID: 16374067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
    Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
    Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
    Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
    Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HER2 and its association with AP-2 in breast cancer.
    Pellikainen J; Naukkarinen A; Ropponen K; Rummukainen J; Kataja V; Kellokoski J; Eskelinen M; Kosma VM
    Eur J Cancer; 2004 Jul; 40(10):1485-95. PubMed ID: 15196531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study.
    Verri E; Guglielmini P; Puntoni M; Perdelli L; Papadia A; Lorenzi P; Rubagotti A; Ragni N; Boccardo F
    Oncology; 2005; 68(2-3):154-61. PubMed ID: 16020953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.